New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BMY;PFE;DUF;CG;HLF;CALM From The Last 14 Days
Check below for free stories on BMY;PFE;DUF;CG;HLF;CALM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 31, 2014
13:46 EDTHLFAckman says Herbalife presentation was 'long and overhyped,' Bloomberg reports
Subscribe for More Information
11:13 EDTHLFCarson Block says 'toyed with the idea' of going short Herbalife
Subscribe for More Information
09:54 EDTPFESunTrust recommends swapping into Merck and out of Pfizer
SunTrust recommends swapping into Merck (MRK) and out of Pfizer (PFE). The firm sees more upside to Merck's numbers and notes Pfize has lost a considerable amount of exclusivity and pipeline contribution will not be enough to make up the difference.
08:40 EDTHLFHerbalife plans to expand manufacturing capabilities in China
Subscribe for More Information
06:24 EDTPFEAstraZeneca offers 'no comment' on Pfizer, Reuters reports
Subscribe for More Information
06:10 EDTBMY, PFEEli Lilly downgraded to Neutral from Buy at Citigroup
Citigroup downgraded Eli Lilly (LLY) to Neutral saying Alimta upside and the company's pipeline is largely priced into shares at current levels. Citi raised its price target for Lilly shares to $66 from $60 and said it prefers Bristol-Myers (BMY) and Pfizer (PFE) in the U.S.
July 30, 2014
10:37 EDTPFEInnoPharma announces launch of generic Zyprexa in Canada
Subscribe for More Information
08:08 EDTPFEBaxter announces divestiture of commercial vaccines business to Pfizer for $635M
Baxter International (BAX) announced that it has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to Pfizer (PFE) for a total cash consideration of $635M, subject to certain adjustments. The sale includes the companyís commercial vaccines business, which is comprised of NeisVac-C, a vaccine which helps protect against meningitis caused by group C meningococcal meningitis, and FSME-IMMUN, which helps protect against tick-borne encephalitis, an infection of the brain transmitted by the bite of ticks infected with the TBE-virus. Both vaccines are currently available outside the United States, primarily in a number of European markets. Baxter continues to explore strategic options, including the potential for partnering or divesting its R&D development programs focused on influenza and Lyme disease. Subject to regulatory approvals and other customary closing conditions, the companies expect to close the transaction by the end of 2014. Baxter expects 2014 vaccines revenues to total approximately $300M and adjusted earnings of approximately 25c per diluted share, including approximately $50M of one-time milestone payments related to the ongoing government collaborations for development of influenza vaccines. Baxter expects the transaction to be modestly dilutive to fourth quarter 2014 adjusted earnings and dilutive to 2015 adjusted earnings by approximately 15c per diluted share.
08:01 EDTPFEPfizer enters into agreement to acquire Baxter's portfolio of marketed vaccines
Subscribe for More Information
06:35 EDTCGCarlyle Group reports Q2 adjusted ENI 73c, consensus 74c
Subscribe for More Information
July 29, 2014
15:53 EDTCGNotable companies reporting before tomorrow's open
Subscribe for More Information
12:13 EDTPFEOn The Fly: Midday Wrap
Subscribe for More Information
11:42 EDTHLFHerbalife says will continue to repurchase shares
Subscribe for More Information
11:16 EDTHLFHerbalife says 'confident' there will be successful conclusion to FTC inquiry
Subscribe for More Information
10:31 EDTPFEPfizer says looking at 'wide spectrum' of M&A transactions
Sees repurchasing 100M more shares this year.
10:20 EDTPFEPfizer says will look at all deals 'regardless of size'
Subscribe for More Information
09:17 EDTHLFOn The Fly: Pre-market Movers
Subscribe for More Information
08:50 EDTPFEHarris & Harris invests in Accelerator Corporation
Subscribe for More Information
07:12 EDTPFEPfizer reports Q2 GEP revenue $6.51B, GIP revenue $3.55B
Subscribe for More Information
07:09 EDTBMY, PFEBristol-Myers, Pfizer granted EU approval for Eliquis for treatment of DVT, PE
Subscribe for More Information
07:06 EDTPFEPfizer sees completing palbociclib filing in advanced breast cancer in August
Subscribe for More Information
07:04 EDTPFEPfizer still sees buying back about $5B in stock this year
Subscribe for More Information
07:03 EDTPFEPfizer backs FY14 adjusted EPS view $2.20-$2.30, consensus $2.24
Lowers FY14 adjusted revenue view to $48.7B-$50.7B from $49.2B-$51.2B previously. The expected negative impact from anticipated multi-source generic competition for Celebrex in the U.S. beginning in December. In addition to the approximate one month of multi-source generic competition, Celebrex revenues also are expected to be negatively impacted in fourth-quarter 2014 by associated wholesaler and retailer destocking.
07:01 EDTPFEPfizer reports Q2 adjusted EPS 58c, consensus 57c
Reports Q2 revenue $12.8B, consensus $12.46B.
06:52 EDTCGFleetCor, buyout companies mull $3B Comdata acquisition, Reuters says
FleetCor Technologies (FLT) and buyout companies including Carlyle Group (CG) and Silver Lake Partners are all looking to purchase Comdata in an agreement which could exceed $3B, according to Reuters, citing people familiar with the matter. Reference Link
05:54 EDTHLFStocks with implied volatility movement; DG HLF
Subscribe for More Information
July 28, 2014
19:54 EDTCGCarlyle Group to purchase full ownership stake of Acosta from Thomas H. Lee firm
Subscribe for More Information
18:31 EDTHLFOn The Fly: After Hours Movers
UP AFTER EARNINGS: Cognex (CGNX), up 16.4% after reporting second quarter results and third quarter revenue guidance above analyst expectations... HealthSouth (HLS), up 7.4% after reporting second quarter results and increasing fiscal 2014 EPS and Adjusted EBITDA guidance... Amkor Technology (AMKR), up 6.4%... Integrated Device (IDTI), up 7.6% after reporting first quarter results... Masco (MAS), up 4.8%. ALSO HIGHER: Darden Restaurants (DRI), up 4.6% following the company's announcement that chairman and CEO Clarence Otis will step down and the board will separate the chairman and CEO roles, appointing lead independent director Charles Ledsinger, Jr., as independent non-executive chairman... Arrowhead Research (ARWR), up 16.5% following positive comments made by CEO Christopher Anzalone, Ph.D. in an interview on CNBC. DOWN AFTER EARNINGS: Herbalife (HLF), down 11.5% after reporting disappointing second quarter results and giving guidance for the third quarter and fiscal 2014... Alliance Fiber Optic (AFOP), down 9.7%... Plum Creek Timber (PCL), down 2.8%... Eastman Chemical (EMN), down fractionally after reporting quarterly results. ALSO LOWER: TCP Capital (TCPC), down 3.1% after filing to sell $5.4M shares of common stock.
17:52 EDTHLFHerbalife plummets after results fall short of estimates
Subscribe for More Information
16:58 EDTHLFHerbalife lowers FY14 volume point growth view to 6%-8% from 8%-10%
Subscribe for More Information
16:47 EDTHLFHerbalife down 8.7% after reporting Q2 results, guidance
Subscribe for More Information
16:40 EDTHLFHerbalife raises FY14 EPS view to $6.17-$6.32 from $6.10-$6.30, consensus $6.30
16:36 EDTHLFHerbalife sees FY14 adjusted EPS $6.17-$6.32, consensus $6.30
Lowers FY14 net sales growth view to 8.5%-10.5% from 10%-12%. FY14 revenue consensus $5.38B.
16:34 EDTHLFHerbalife sees Q3 adjusted EPS $1.49-$1.53, consensus $1.62
Sees Q3 net sales growth 9%-11%. Q3 revenue consensus $1.34B.
16:33 EDTHLFHerbalife reports Q2 EPS $1.55, consensus $1.57
Subscribe for More Information
15:47 EDTPFENotable companies reporting before tomorrow's open
Subscribe for More Information
15:47 EDTHLFNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include General Growth Properties (GGP), consensus 30c; Eastman Chemical (EMN), consensus $1.84; Range Resources (RRC), consensus 40c; XL Group (XL), consensus 83c; Plum Creek Timber (PCL), consensus 30c; Masco (MAS), consensus 28c; Jacobs Engineering (JEC), consensus 80c; Herbalife (HLF), consensus $1.57; W.R. Berkley (WRB), consensus 77c; HEALTHSOUTH (HLS), consensus 47c; Denny's (DENN), consensus 8c; Integrated Device Technology (IDTI), consensus 16c; Advent Software (ADVS), consensus 34c; Tile Shop Holdings (TTS), consensus 11c; Meru Networks (MERU), consensus (11c); Crane Co. (CR), consensus $1.16.
15:45 EDTHLFHerbalife August weekly 67 straddle priced for 7.6% move into Q2
Subscribe for More Information
13:12 EDTPFEEarnings Preview: Pfizer looks for earnings boost from Lyrica, Xalkori
Subscribe for More Information
12:52 EDTCGCarlyle in advanced discussions to acquire Acosta, Reuters says
Subscribe for More Information
11:58 EDTCALMPoultry leaders Tyson, Cal-Maine diverge after quarterly reports
Shares of two leaders in the poultry industry, Tyson Foods (TSN) and Cal-Maine Foods (CALM), are moving in opposite directions following their respective quarterly reports. Tyson, a food production company specializing in chicken and other proteins, were up after the company reported better than expected third quarter revenues, while shares of egg provider Cal-Maine are cracking after the company said it was "cautiously optimistic" about having a good start to full-year 2015. TYSON: Tyson Foods' adjusted Q3 earnings per share was 75c, which fell below analysts' consensus of 78c. The food provider's Q3 revenue was $9.68B, which exceeded analysts' consensus of 9.47B. In terms of guidance, Tyson guided fiscal year 2014 revenue to grow to $38B, compared to analysts' estimates of $36.85B. Tyson expects FY15 EPS growth of at least 10%. Analysts are expecting the company's FY15 EPS to be $3.16. The company sees FY15 revenue of $42B, above the analysts' consensus of $38.75B. Tyson Foods said that it expects fiscal year 2015 domestic protein production to increase 1% and also expects grain supplies to increase during the fiscal year, which should result in lower input costs as well as decreased costs for cattle and hog producers. U.S. chicken production is expected to increase around 2% in FY15 compared to FY14. The company expects lower feed costs for chicken in FY15 and said the Chicken segment's operating margin should be at or above 10% in FY15. Tyson also announced that has reached a definitive agreement with to sell its poultry businesses in Mexico and Brazil to Pilgrim's Pride (PPC), whose majority owner is a wholly owned subsidiary of JBS SA (JBSAY). On its earnings conference call, Tyson backed its FY14 EPS view of "at least" $2.78, versus analysts' estimates of $2.91, and called 2015 earnings guidance "conservative." The company said the Hillshire Brands (HSH) acquisition is on-track to close in Q4 and sees synergies reaching $225M in 2015. CAL-MAINE: Meanwhile, Cal-Maine reported fourth quarter EPS of $1.30, which surpassed the consensus forecast of $1.15 from the two analysts covering the stock, according to First Call. The company's Q4 revenue was $371.6M, which was over $46M higher than the revenue it reported a year ago in the same period. Cal-Maine reported that it produced 195.63M total dozen eggs in Q4 and sold 249.44M total dozen eggs in the quarter. The company said its results reflect strong demand for shell eggs throughout the year from all the major market segments including retail, egg product and exports. Looking ahead to its FY15, Cal-Maine said that it is "cautiously optimistic" about a good start to the upcoming year. The company said current USDA projections for harvested acres and yields for both crops should be favorable for end users and help reduce feed costs in FY15. ANALYST REACTION: Sidoti downgraded Cal-Maine to Neutral from Buy due to valuation. The firm maintained its price target of $87 on the shares. PRICE ACTION: Near midday, shares of Tyson Foods rose $1.70, or 4.3%, to $41.24 and CalMaine foods fell $4.70. or 6%, to $74.59.
11:30 EDTHLFHerbalife technical comments before results
Subscribe for More Information
11:18 EDTHLFOptions with decreasing implied volatility
Subscribe for More Information
10:02 EDTPFEOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AcelRx (ACRX) downgraded to Hold from Buy at Canaccord... Anglo American (AAUKY) downgraded to Neutral from Buy at UBS... Aon plc (AON) downgraded to Hold from Buy at Sandler ONeill... Cabot Oil & Gas (COG) downgraded at Oppenheimer... Cisco (CSCO) downgraded to Sector Perform from Outperform at Pacific Crest... Coeur Mining (CDE) downgraded to Market Perform from Outperform at Raymond James... DSW (DSW) downgraded at Sterne Agee... DuPont Fabros (DFT) downgraded to Neutral from Buy at Citigroup... El Paso Electric (EE) downgraded to Hold from Buy at Jefferies... Enphase Energy (ENPH) downgraded to Hold from Buy at Deutsche Bank... GlaxoSmithKline (GSK) downgraded to Neutral from Buy at BofA/Merrill... Horizon Technology (HRZN) downgraded to Hold from Buy at Wunderlich... Lear (LEA) downgraded to Hold from Buy at Deutsche Bank... Life Time Fitness (LTM) downgraded at Wedbush... Monster Beverage (MNST) downgraded to Neutral from Buy at UBS... NRG Energy (NRG) downgraded to Buy from Conviction Buy at Goldman... PG&E (PCG) downgraded to Sell from Neutral at Goldman... Pfizer (PFE) downgraded at BMO Capital... Post Properties (PPS) downgraded to Neutral from Buy at Citigroup... Publicis (PUBGY) downgraded to Sell from Neutral at Citigroup... Selmer Scientific (SMLR) downgraded to Hold from Buy at Aegis... TransCanada (TRP) downgraded to Neutral from Outperform at Credit Suisse... Travelers (TRV) downgraded to Hold from Buy at Sandler O'Neill... Zurich Insurance (ZURVY) downgraded to Underperform from Market Perform at Bernstein.
09:31 EDTCALMCal-Maine Foods downgraded to Neutral from Buy at Sidoti
Sidoti downgraded Cal-Maine Foods due to valuation. Price target is $87.
08:43 EDTPFEPfizer downgraded at BMO Capital
As noted earlier, BMO Capital downgraded Pfizer to Market Perform from Outperform. As reasons for the downgrade, the firm cited what it sees as the weakening of the company's mature franchises and significant loss of exclusivity headwinds in 2015. Target to $31 from $34.
08:10 EDTCGOrtho-Clinical Diagnostics, Astute Medical to develope acute kidney injury tests
Subscribe for More Information
06:36 EDTPFEPfizer downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information
06:34 EDTCALMCal-Maine Foods is 'cautiously optimistic' about good start to FY15
Subscribe for More Information
06:34 EDTCALMCal-Maine Foods reports Q4 total dozens eggs produced 195.63M
Reports Q4 total dozens eggs sold 249.44M
06:33 EDTCALMCal-Maine Foods reports Q4 EPS $1.30, consensus $1.15
Subscribe for More Information
05:55 EDTPFEStocks with implied volatility movement; IGT PFE
Subscribe for More Information
July 25, 2014
16:01 EDTCALMCal-Maine Foods announces new JV for specialty egg sales in Arizona
Cal-Maine Foods announced the company has entered into a new joint venture for specialty egg sales with Hickmanís Egg Ranch. Based in Buckeye, Arizona, a suburb of Phoenix in western Maricopa County, Hickmanís Egg Ranch has been family-owned and operated since 1944. With processing operations located in Arizona, Colorado and California, and capacity for approximately 6M laying hens, Hickmanís Egg Ranch ranks among the top twenty family egg farms in the United States. Pursuant to this transaction, the new joint venture, known as Southwest Specialty Eggs, will acquire the Egg-Landís Best, franchise for the state of Arizona with exclusive licensing agreements for the sale of Egg-Landís Best and Land Oí Lakes branded specialty eggs and other premium brands. Sales of Egg-Landís Best specialty eggs accounted for approximately 14.3% of Cal-Maineís total shell egg sales in fiscal 2013.
08:28 EDTHLFHerbalife confirms Alan Hoffman as EVP of global corporate affairs
Subscribe for More Information
07:29 EDTPFEEMA recommends indication for Ecalta to treat invasive candidiasis
The Committee for Medicinal Products for Human Use adopted a positive opinion recommending a variation to the terms of the marketing authorization for the medicinal product Ecalta, offered by Pfizer. The CHMP adopted a change to an indication as follows: "Treatment of invasive candidiasis in adult patients."
07:27 EDTBMYEMA recommends expanded indication for Baraclude
Subscribe for More Information
07:11 EDTHLFHerbalife hires VP's former chief of staff to help fight Ackman, NY Post says
Herbalife, which is under continued attack from investor Bill Ackman and being investigated by the FTC, is hiring Alan Hoffman, Vice President Joe Bidenís former chief of staff, to "fight back against Bill Ackmanís multi-front efforts ó both here on Capitol Hill, with federal regulators, and now state AGs all across the states,Ē said The New York Post, citing a Washington insider. Reference Link
06:00 EDTBMYBristol-Myers implied volatility of 17 at lower end of index mean range
Subscribe for More Information
July 24, 2014
11:22 EDTBMYBristol-Myers says considering different sizes of deal opportunities
Subscribe for More Information
10:57 EDTBMYBristol-Myers says M&A would have to be good strategic fit
Subscribe for More Information
10:48 EDTBMYBristol-Myers says guidance assumes R&D credit will be extended
Says Reyataz seeing increased competitive pressure. Says business development a top priority for capital allocation. Comments made on the Q2 earnings conference call.
08:30 EDTCGCarlyle may be last firm in rigging suit as peers near settlement, NY Post says
Carlyle Group (CG) may soon be the only private equity firm left to settle a suit that accused it and several of its peers of conspiring to hold down deal prices and one source close to the situation said ďmy expectation is there will be a trial,Ē according to The New York Post. Bain Capital, Silver Lake and Goldman Sachs (GS) previously settled for a combined $150.5M and KKR (KKR), Blackstone (BX) and TPG Capital are expected to settle for an amount above that "within days," the report said. Reference Link
08:28 EDTBMYBristol-Myers management to meet with JPMorgan
Subscribe for More Information
07:32 EDTBMYBristol-Myers reaffirms 2014 EPS outlook $1.70-$1.80, consensus $1.77
Subscribe for More Information
07:31 EDTBMYBristol-Myers reports Q2 EPS 48c, consensus 44c
Reports Q2 revenue $ $3.89B, consensus $3.85B.
05:26 EDTBMYBristol-Myers, Ono Pharmaceutical announces strategic collaboration in Japan
Bristol-Myers Squibb and Ono Pharmaceutical have signed a strategic collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea and Taiwan. As part of the agreement, Bristol-Myers Squibb and Ono will jointly develop and commercialize Opdivo and Yervoy across a broad range of tumor types. Bristol-Myers Squibb and Ono will jointly pursue development of monotherapy and combination regimens, with Opdivo as the foundational therapy in Japan, South Korea and Taiwan, and leverage global clinical trials by including patients from the three countries.
July 23, 2014
15:30 EDTBMYNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Ford (F), consensus 36c; General Motors (GM), consensus 58c; Potash (POT), consensus 46c; Caterpillar (CAT), consensus $1.52; 3M (MMM), consensus $1.91; Union Pacific (UNP), consensus $1.43; Bristol-Myers Squibb (BMY), consensus 44c; Eli Lilly (LLY), consensus 65c; Celgene (CELG), consensus 89c; Precision Castparts (PCP), consensus $3.35; Raytheon (RTN), consensus $1.59; Noble Energy (NBL), consensus 79c; Hershey (HSY), consensus 76c; Southwest Airlines (LUV), consensus 61c; Boston Scientific (BSX), consensus 19c; JetBlue (JBLU), consensus 19c.
15:10 EDTBMYBristol-Myers technical comments before earnings
Subscribe for More Information
12:01 EDTHLFStocks with call strike movement; AAPL HLF
Subscribe for More Information
08:01 EDTCGBlackstone acquires majority stake in Service King Collision Repair Centers
Subscribe for More Information
07:14 EDTHLFAckman accused of lying during Herbalife presentation by Ramey, CNBC says
Subscribe for More Information
July 22, 2014
19:34 EDTCGJPMorgan in advanced talks to sell half its stake in buyout arm, WSJ says
Subscribe for More Information
16:36 EDTHLFOn The Fly: Closing Wrap
Subscribe for More Information
16:18 EDTPFEPuma Biotech now responsible for R&D expenses associated with legacy trials
Subscribe for More Information
15:49 EDTCGBlackstone to buy majority stake in Service King from Carlyle, WSJ says
Blackstone's (BX) purchase from Carlyle Group (CG) of the majority stake in the repair chain values the company at about $650M, according to The Wall Street Journal, citing a source. Reference Link
15:05 EDTHLFHerbalife says Ackman claim about nutrition clubs' earnings 'false, fabricated'
Subscribe for More Information
15:03 EDTHLFHerbalife says Ackman 'over-promised and under-delivered' with presentation
Subscribe for More Information
14:38 EDTHLFHerbalife CFO says Ackman 'completely misunderstood' Club 100
Subscribe for More Information
14:25 EDTCGBlackstone to buy majority stake in Service King from Carlyle, Dow says
Subscribe for More Information
13:23 EDTHLFAckman says has never met Senator Markey
Subscribe for More Information
13:02 EDTHLFRob Chapman says Herbalife can hit $150 next summer
Subscribe for More Information
12:44 EDTHLFHerbalife volatility decreases on Bill Ackman presentation
Subscribe for More Information
12:29 EDTHLFOn The Fly: Midday Wrap
Subscribe for More Information
12:26 EDTHLFAckman says Canadian government investigating Herbalife
Subscribe for More Information
11:59 EDTHLFAckman estimates nutrition clubs contribute 'enormously' to Herbalife results
Ackman says Herbalife insiders are selling while the company is repurchasing shares. Bill Ackman continues his presentation on Herbalife.
11:25 EDTHLFHerbalife says alleged $12K average Nutrition Club loss 'just false'
Subscribe for More Information
11:20 EDTHLFHerbalife Club 100 relies on deceptive income claims, Pershing alleges
11:07 EDTHLFOptions with increasing implied volatility: HLF JOY PSEC NI
11:03 EDTHLFHerbalife near session highs, up 7.7% as Ackman presentation continues
Subscribe for More Information
10:46 EDTHLFHigh option volume stocks: SBAC KS EDU PII GALT EJ AXL TSEM HLF BCOR
Subscribe for More Information
10:29 EDTHLFAckman estimates Herbalife nutrition clubs lose money for operators
Ackman alleges real purpose of nutrition clubs is recruitment. Pershing's Bill Ackman continues speaking on his Herbalife webcast.
10:11 EDTHLFHerbalife targeting 'bottom of the pyramid,' says Ackman
Subscribe for More Information
09:58 EDTHLFHerbalife July weekly volatility spikes into Bill Ackman presentation
Subscribe for More Information
09:21 EDTHLFHerbalife CFO says has 'complete confidence' in compliance in regulations
Subscribe for More Information
09:18 EDTHLFHerbalife: Economist says U.S. ops 'inconsistent' with pyramid scheme model
Subscribe for More Information
06:31 EDTHLFHerbalife volatility elevated into Bill Ackman presentation
Subscribe for More Information
05:53 EDTHLFStocks with implied volatility movement; HLF MSFT
Subscribe for More Information
July 21, 2014
15:26 EDTHLFAckman says Herbalife presentation will probe nutrition clubs
Subscribe for More Information
14:45 EDTHLFHerbalife releases new video highlighting 'positive impact' of nutrition clubs
Subscribe for More Information
14:02 EDTHLFHerbalife falls after Ackman teases presentation on coming 'collapse'
Subscribe for More Information
13:55 EDTHLFIcahn has not sold 'single share' of Herbalife, Gasparino says
"Sources tell @FoxBusiness uncle @Carl_C_Icahn has not sold a single $hlf share," Fox Business' Charles Gasparino stated on Twitter. Reference Link
13:45 EDTHLFHerbalife puts active ahead of Bill Ackman presentation
Subscribe for More Information
13:04 EDTHLFHerbalife spikes lower on Ackman comments, levels to watch
Shares are down over 6.3% to $56.92 at time of writing after Bill Ackman stated that he was going to expose an "incredible fraud" tomorrow at 10am ET, detailing why he believes the company will collapse. At current price next support is at $56.18, the low of the day. Resistance is at $57.91.
12:51 EDTHLFHerbalife sinks 6% after Ackman says presentation will detail collapse
12:49 EDTHLFAckman says going to expose 'incredible fraud' tomorrow
Subscribe for More Information
12:48 EDTHLFAckman says Herbalife presentation tomorrow most important of career
Subscribe for More Information
12:46 EDTHLFAckman says Herbalife presentation will show why company will collapse
Bill Ackman of Pershing Square is speaking on CNBC.
06:43 EDTBMYGrowing market for hepatitis-C treatment prompts legal scramble, WSJ says
Subscribe for More Information
July 18, 2014
09:01 EDTHLFHerbalife says independent members 'demand opponents stop lies and smears'
Subscribe for More Information
07:14 EDTCGBlackstone, KKR, TPG discussing deal collusion suit settlement, Reuters says
Blackstone (BX), KKR (KKR) and TPG Capital are in discussions to settle a U.S. case accusing the firms of conspiring not to outbid one another and other buyout companies on takeovers of firms, according to Reuters, citing two people familiar with the matter. If all three companies settled, the Carlyle Group (CG) would be the only private equity company still up against a trial among 11 firms originally accused of colluding in agreements before the financial crisis occurred. Reference Link
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use